BURJEEL HOLDINGS PLC
AADX:BURJEEL1.16
AED
-0.01
(-0.85%)
ISIN
AEE01119B224
Return %
Stock
S&P 500
1Y
-15.33
14.20
3Y
-53.23
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Shamsheer Vayalil Parambath Pokkinari Hashim
- Full Time Employees
- 14,088
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Abu Dhabi United Arab Emirates
- IPO Date
- Oct 10, 2022
- Website
- burjeelholdings.com
- Similar Companies
- Business
- Burjeel Holdings PLC is an Abu Dhabi-based private healthcare services provider offering multi-specialty clinical care, tertiary and quaternary healthcare, outpatient medical consultations, and allied wellness services across the Middle East and international markets. Founded in 2007 and headquartered in Abu Dhabi, United Arab Emirates, the company operates an integrated hub-and-spoke healthcare network comprising hospitals, medical centers, day surgery clinics, retail pharmacies, and specialized rehabilitation facilities across the United Arab Emirates, the Kingdom of Saudi Arabia, the Sultanate of Oman, and the United Kingdom. The company operates through four core business segments: Hospitals, Medical Centres, Pharmacies, and Other Healthcare Support Services. Its portfolio of healthcare brands and specialized service offerings includes Burjeel, its flagship premium multi-specialty brand anchored by Burjeel Medical City, a 400-bed quaternary care facility in Abu Dhabi; Medeor Hospital, providing multi-disciplinary family and community clinical care; LLH Hospital and Lifecare Hospital, delivering comprehensive secondary and acute clinical care to core workforce and industrial demographics; Lifeline Clinics; Tajmeel, specializing in medical aesthetics, cosmetology, and dental care; International Knee & Joint Center, delivering specialized orthopedic and sports medicine treatments; Trust Fertility Clinic, providing assisted reproductive technology and fertility services; and PhysioTherabia, a joint-venture network offering advanced physical therapy, rehabilitation, musculoskeletal recovery, and sports wellness services. Burjeel Holdings delivers specialized clinical services spanning complex oncology; pediatric hematology and bone marrow transplantation; cardiovascular and thoracic surgery; neurosurgery and neurology; fetal medicine and high-risk obstetrics; robotic-assisted minimally invasive surgery; orthopedic and spine surgery; pediatric and neonatal intensive care; diagnostic imaging and pathology laboratory services; emergency and critical care; chronic disease management; and retail pharmaceutical dispensing. In recent developments, Burjeel Holdings has accelerated regional and international expansion across key geographic markets. The company expanded into the European healthcare sector through the acquisition of a specialized nursing and long-term care facility in the United Kingdom to integrate advanced elderly care clinical protocols into its Middle Eastern operations. Across the Gulf region, Burjeel has advanced the rapid rollout of its PhysioTherabia physiotherapy and rehabilitation network in Saudi Arabia in partnership with Leejam Sports Company, alongside developing minimally invasive day surgery centers under the Burjeel One brand in Riyadh and Al Khobar. In the United Arab Emirates, the group expanded community healthcare access by opening multiple primary care clinics across Abu Dhabi, Dubai, and Al Ain, while initiating development pipelines for new hospitals, day surgery facilities, and fertility clinics. To finance its strategic infrastructure expansion, clinical research, digital health transformation, and artificial intelligence-driven medical capabilities, Burjeel established a 1.5 billion dollar multi-currency trust certificate (Sukuk) programme listed on the London Stock Exchange, while establishing strategic clinical alliances with international institutions and specialized healthcare partners.